Image

Examination of the informed consent process as experienced by patients who have undergone a chemoembolization radioembolization or transjugular intrahepatic portosystemic shunt (TIPS) procedure

Study on Patient Experiences with a TIPS Procedure

Recruiting
100 years and younger
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the experiences of patients who have undergone a de novo TIPS procedure. A TIPS procedure, or Transjugular Intrahepatic Portosystemic Shunt, is a medical procedure that creates a channel in the liver to improve blood flow. This study aims to understand how patients experience this procedure and the process of providing informed consent (IC).

Participants in the study will be asked about their experiences with informed consent and the TIPS procedure. The study will involve completing assessments such as the Newest Vital Sign (NVS), which helps evaluate health literacy. Participants will provide insights into their understanding and feelings about the TIPS procedure.

  • Who can participate: Adults aged 18 and older who have undergone a de novo TIPS procedure, chemoembolization, or radioembolization in the last three months can participate. Participants must have signed the consent form themselves and be able to read, write, and speak English. They also need to agree to complete the NVS assessment.
  • Study details: Participants will be asked to share their experiences with the TIPS procedure and the informed consent process. They will complete the Newest Vital Sign (NVS) assessment, which measures health literacy.
Print
Study details
    transjugular intrahepatic portosystemic shunt (TIPS) procedure
    radioembolization
    chemoembolization

TX6289

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.